Service Corporation International header image

Service Corporation International

SCI

Equity

ISIN US8175651046 / Valor 969683

New York Stock Exchange, Inc (2024-09-18)
USD 79.54-1.27%

Service Corporation International
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Service Corporation International (SCI), established in 1962, operates as the premier provider of funeral, cremation, and cemetery services in North America. The company has built a reputation for offering compassionate and professional care to families navigating the complexities of losing a loved one. Annually, SCI assists over 450,000 families, demonstrating its significant role in the death care industry. Through a broad network of facilities and services, SCI addresses the diverse needs and preferences of the communities it serves, ensuring that each family receives support tailored to their unique situation. This comprehensive approach to funeral and cemetery services underscores SCI's commitment to excellence in a sector that demands sensitivity, respect, and professionalism.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Revenue Growth

Service Corporation International reported revenue of $1,034.0 million for the second quarter of 2024, an increase from $1,013.4 million in the same quarter of 2023. This growth was driven in part by the performance of the cemetery segment, which contributed to the overall revenue increase.

Earnings Per Share

The diluted earnings per share for Service Corporation International in the second quarter of 2024 was $0.81, compared to $0.86 in the second quarter of 2023. Adjusted earnings per share, excluding special items, were $0.79 in the current quarter, down from $0.83 in the prior year quarter.

Net Cash Provided by Operating Activities

Service Corporation International saw a significant increase in net cash provided by operating activities, which grew to $196.9 million in the second quarter of 2024 from $144.1 million in the same period of 2023. Excluding special items, net cash provided by operating activities was $219.9 million, up from $157.4 million in the prior year quarter.

Comparable Core Preneed Funeral Sales

In the second quarter of 2024, Service Corporation International's comparable core preneed funeral sales production increased by $9.7 million, or 4.0%, compared to the same quarter in 2023. Additionally, the comparable core funeral sales average grew by 1.3% in the current quarter.

Outlook for 2024

Service Corporation International has maintained its guidance ranges for 2024 as previously reported. Despite experiencing a higher than anticipated decline in funeral services performed during the latter part of the second quarter, the company remains confident in its long-term growth strategy and continues to focus on revenue growth, leveraging scale, and wise capital allocation to enhance shareholder value.

Summarized from source with an LLMView Source

Key figures

30.5%1Y
28.8%3Y
68.2%5Y

Performance

24.9%1Y
25.8%3Y
29.4%5Y

Volatility

Market cap

11486 M

Market cap (USD)

Daily traded volume (Shares)

280,164

Daily traded volume (Shares)

1 day high/low

80.47 / 79.46

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Heidelberg Pharma AG
Heidelberg Pharma AG Heidelberg Pharma AG Valor: 24937540
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%EUR 2.36
AtriCure Inc
AtriCure Inc AtriCure Inc Valor: 2134051
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.29%USD 27.99
KK Milbon
KK Milbon KK Milbon Valor: 463028
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.14%JPY 2,958.00
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%USD 44.06
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 67.11
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc Amneal Pharmaceuticals Inc Valor: 41368351
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.36%USD 8.71
Rohto Seiyaku KK
Rohto Seiyaku KK Rohto Seiyaku KK Valor: 763212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.16%JPY 3,482.00
Asahi Intecc KK
Asahi Intecc KK Asahi Intecc KK Valor: 1872022
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.12%JPY 2,599.00
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.38%GBP 0.21
Nihon Koden Kogyo KK
Nihon Koden Kogyo KK Nihon Koden Kogyo KK Valor: 762894
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%JPY 2,097.00